Company · CIK 1962738
CASI Pharmaceuticals, Inc.
| CIK | 1962738 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | China |
| Listed | CASIF (OTC) |
| First annual or quarterly report | 2023-04-26 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-283998 | 2024-12-20 | 2025-04-01 | 3 | |
| 333-281621 | 2024-08-16 | 2024-09-03 | 2 | |
| 333-279096 | 2024-05-03 | 2024-05-10 | 2 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-04-01 | 424B5Shelf takedown | 333-283998 | 0001104659-25-030307 |
| 2024-12-31 | EFFECTDeclared effective | 333-283998 | 9999999995-25-000018 |
| 2024-12-20 | F-3Shelf registered | 333-283998 | 0001104659-24-130920 |
| 2024-09-03 | EFFECTDeclared effective | 333-281621 | 9999999995-24-002707 |
| 2024-08-16 | F-3Shelf registered | 333-281621 | 0001104659-24-090555 |
| 2024-05-10 | EFFECTDeclared effective | 333-279096 | 9999999995-24-001491 |
| 2024-05-03 | F-3Shelf registered | 333-279096 | 0001962738-24-000018 |
| 2023-02-13 | EFFECTDeclared effective | 333-269479 | 9999999995-23-000406 |